Marion M. Nau

11.2k citations

75 papers · 9.2k indexed · 5 hit papers · h-index 43

Molecular Biology top 1%
Oncology top 0.5%
Cancer Research top 0.5%
Pulmonary and Respiratory Medicine top 2%
Genetics top 2%

Co-authors: John D. Minna Adi F. Gazdar Desmond N. Carney Seth A. Ettenberg Stanley Lipkowitz Maccon Keane Stan Lipkowitz Philip Leder
Topics: Cancer-related Molecular Pathways (20 papers)RNA modifications and cancer (15 papers)Glycosylation and Glycoproteins Research (11 papers)
Cited by: Oncology Cancer Research Molecular Biology
Journals: Nature Science Cell
Partner nations: United States Ukraine Chile

In The Last Decade

Marion M. Nau

73 papers receiving 8.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

1989 1.1k citations Takashi Takahashi, Marion M. Nau et al. profile →
Amplification and expression of the c-myc oncogene in human lung cancer cell lines

1983 775 citations Marion M. Nau, Adi F. Gazdar et al. profile →
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

1985 543 citations Marion M. Nau, James F. Battey et al. profile →
Differential expression of myc family genes during murine development

1986 480 citations Marion M. Nau, John D. Minna et al. profile →
Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.

1985 397 citations Adi F. Gazdar, Marion M. Nau et al. profile →

Peers

Countries citing papers authored by Marion M. Nau

Since Specialization

Citations

This map shows the geographic impact of Marion M. Nau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion M. Nau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion M. Nau more than expected).

Fields of papers citing papers by Marion M. Nau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion M. Nau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion M. Nau. The network helps show where Marion M. Nau may publish in the future.

Co-authorship network of co-authors of Marion M. Nau

This figure shows the co-authorship network connecting the top 25 collaborators of Marion M. Nau. A scholar is included among the top collaborators of Marion M. Nau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion M. Nau. Marion M. Nau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of function Cbl-c mutations in solid tumors 2019 ·PLoS ONE ·(unknown),(unknown),Stephen C. Kales,Marion M. Nau,Philip Ryan,Jeffrey E. Green,Stanley Lipkowitz	10
2	Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A 2014 ·PLoS ONE ·Stephen C. Kales,Marion M. Nau,Anand S. Merchant,Stanley Lipkowitz	22
3	Cbl-c Ubiquitin Ligase Activity Is Increased via the Interaction of Its RING Finger Domain with a LIM Domain of the Paxillin Homolog, Hic 5 2012 ·PLoS ONE ·Philip Ryan,Stephen C. Kales,(unknown),Marion M. Nau,Han Zhang,Stanley Lipkowitz	15
4	Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression 2011 ·Prostate Cancer and Prostatic Diseases ·(unknown),Bungo Furusato,Syed Shaheduzzaman,Vasantha Srikantan,Zhongchang Wang,(unknown),Mary Lou Siefert,Lakshmi Ravindranath,Denise Young,Marion M. Nau,Albert Dobi,Thomas Werner,D. G. R. McLeod,Maryanne Vahey,Isabell A. Sesterhenn,Shiv Srivastava,György Petrovics	56
5	Brain activation during immediate and delayed reaching in optic ataxia 2009 ·Neuropsychologia ·Marc Himmelbach,Marion M. Nau,(unknown),Michael Erb,Marie-Thérèse Perenin,Hans‐Otto Karnath	42
6	TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype 2008 ·Breast Cancer Research and Treatment ·Monzur Rahman,Sean Davis,Janet G. Pumphrey,Jing Bao,Marion M. Nau,Paul S. Meltzer,Stanley Lipkowitz	147
7	Regulating the regulator: negative regulation of Cbl ubiquitin ligases 2006 ·Trends in Biochemical Sciences ·Philip Ryan,Gareth Davies,Marion M. Nau,Stanley Lipkowitz	77
8	Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b 2004 ·Oncogene ·Gareth Davies,Seth A. Ettenberg,(unknown),(unknown),Sarangan Ravichandran,(unknown),Marion M. Nau,Stan Lipkowitz	71
9	N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines 2004 ·Cell Death and Differentiation ·Mauricio Cuello,(unknown),(unknown),Seth A. Ettenberg,Ginger J. Gardner,Marion M. Nau,(unknown),Michael J. Birrer,Stanley Lipkowitz	36
10	Comparative genomic organization of the cbl genes 2003 ·Gene ·Marion M. Nau,Stan Lipkowitz	39
11	Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines 2000 ·Breast Cancer Research and Treatment ·Maccon Keane,Yaffa Rubinstein,Mauricio Cuello,Seth A. Ettenberg,Priya R. Banerjee,Marion M. Nau,Stan Lipkowitz	87
12	cbl-b inhibits epidermal growth factor receptor signaling 1999 ·Oncogene ·Seth A. Ettenberg,Maccon Keane,Marion M. Nau,Mark Frankel,Ling-Mei Wang,Jacalyn H. Pierce,Stan Lipkowitz	103
13	Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines 1998 ·Oncogene ·(unknown),Marion M. Nau,(unknown),Tomi P. Mäkelä,Kari Alitalo,Bruce E. Johnson,Michael J. Kelley	19
14	LINE-I element insertion at the t(11;22) translocation breakpoint of a desmoplastic small round cell tumor 1997 ·Genes Chromosomes and Cancer ·Jun Liu,Marion M. Nau,Jessica Zucman‐Rossi,John Powell,Carmen J. Allegra,James R. Wright	35
15	Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. 1992 ·Journal of Clinical Investigation ·Carolyn A. Felix,D D’Amico,Tetsuya Mitsudomi,Marion M. Nau,(unknown),Joseph F. Fraumeni,Diane E. Cole,(unknown),Gregory H. Reaman,J. Whang‐Peng	34
16	Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. 1992 ·Journal of Clinical Investigation ·Carolyn A. Felix,Marion M. Nau,Takashi Takahashi,Tetsuya Mitsudomi,Itsuo Chiba,(unknown),Gregory H. Reaman,Diane E. Cole,John J. Letterio,Jacqueline Whang‐Peng	84
17	Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancer 1991 ·Genes Chromosomes and Cancer ·Jacqueline Whang‐Peng,Tor Knutsen,Adi F. Gazdar,S. M. Steinberg,Herbert K. Oie,Ilona Linnoila,James L. Mulshine,Marion M. Nau,John D. Minna	86
18	Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer 1989 ·International Journal of Cancer ·John D. Minna,J. Schütte,Jean Viallet,François Thomas,Frederic J. Kaye,Takashi Takahashi,Marion M. Nau,Jacqueline Whang‐Peng,Michael J. Birrer,Adi F. Gazdar	10
19	Constitutive expression of multiple messenger rna forms of the c jun oncogene in human lung cancer cell lines 1988 ·(unknown),Marion M. Nau,Michael J. Birrer,(unknown),(unknown),John D. Minna	10
20	Multiple Mechanisms for Transcriptional Regulation of the myc Gene Family in Small-Cell Lung Cancer 1988 ·Molecular and Cellular Biology ·Geoffrey W. Krystal,Michael J. Birrer,James M. Way,Marion M. Nau,Edward A. Sausville,Craig B. Thompson,John D. Minna,James F. Battey	5

About Marion M. Nau

Marion M. Nau is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 75 papers that have together received 9.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), RNA modifications and cancer (15 papers) and Glycosylation and Glycoproteins Research (11 papers). The work is most often cited by research in Oncology (4.2k citations), Cancer Research (1.7k citations) and Molecular Biology (6.0k citations). Marion M. Nau has collaborated with scholars based in United States, Ukraine and Chile. Frequent co-authors include John D. Minna, Adi F. Gazdar, Desmond N. Carney, Seth A. Ettenberg, Stanley Lipkowitz, Maccon Keane, Stan Lipkowitz, Philip Leder, Michael J. Birrer and J D Minna. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact